GO:0003279 cardiac septum development: Heart Septum Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003279 cardiac septum development describes the progression of a cardiac septum from its initial formation to the mature structure.
• The process builds the atrial and ventricular septa that separate the heart into four chambers, a prerequisite for the mature mammalian circulation.
• Mesodermal transcription factors such as Moz are required for cardiac septum development, and loss of Moz causes septal defects in mice.
• MEIS2 has been linked to cleft palate and cardiac septum anomalies in humans, supporting a conserved role for homeodomain proteins in septation.
• Septal malformations are among the most common congenital heart defects and are studied with knockout, knock-in and lineage-tracing models.
• CRISPR-based knockout, point-mutation and knock-in cell and animal models allow causal testing of candidate septation genes.
Description
Cardiac septum development (GO:0003279) is the biological process by which the embryonic heart builds the muscular and membranous partitions that divide the atrial and ventricular chambers. The term covers the entire progression of a cardiac septum over time, from its initial formation to the mature structure, and is therefore broader than any single anatomical event such as atrial septation or ventricular septation. Because the mature heart depends on complete septation for separate pulmonary and systemic circulations, defects in this process are a major source of congenital heart disease. Researchers study GO:0003279 to identify the genes, signaling pathways and cell behaviors that build the septa and to understand how their disruption causes disease. The process is experimentally tractable: mouse genetics has shown that mesodermal expression of Moz is necessary for cardiac septum development, and human genetics has provided evidence that MEIS2 contributes to cleft palate and cardiac septum anomalies. These findings make cardiac septum development a model ontology term for combining developmental biology, human genetics and CRISPR-based functional testing.
cardiac septum development At A Glance
| GO ID | GO:0003279 |
|---|---|
| GO term | cardiac septum development |
| Ontology | biological_process |
| Synonym | heart septum development |
| Definition | The progression of a cardiac septum over time, from its initial formation to the mature structure. |
| Major function | Formation and maturation of the partitions that separate the cardiac chambers |
| Related anatomy | Atrial septum, ventricular septum and the membranous septum of the heart |
| Key experimental genes | Moz, MEIS2 |
| Human disease link | Congenital heart defects including septal defects and cleft palate with cardiac septum anomalies |
What Is GO:0003279?
In plain terms, GO:0003279 cardiac septum development is the timed series of events through which a cardiac septum forms and matures. The QuickGO definition states that it is the progression of a cardiac septum over time, from its initial formation to the mature structure. This includes the specification of septal precursor cells, their proliferation and migration, the formation of the primary septum, and the remodeling that produces the definitive atrial and ventricular septa. The synonym heart septum development is used interchangeably. The term is a biological process and should not be confused with the anatomical structure of the septum itself; it describes the developmental program that creates that structure.
Why Is cardiac septum development Important in Cell Biology?
Cardiac septum development is important because the separation of the heart into four chambers is essential for efficient pulmonary and systemic circulation, and failure of septation produces some of the most common congenital heart defects. Understanding GO:0003279 therefore has direct clinical relevance: it identifies the genes and cell behaviors whose disruption causes atrial and ventricular septal defects. The process also serves as a paradigm for how mesodermal transcription factors and homeodomain proteins control organ morphogenesis, making it a productive area for developmental and genetic research.
• Septation is required for separate pulmonary and systemic circulations in the mature heart.
• Defects in cardiac septum development are a major category of congenital heart disease.
• Mesodermal transcription factor Moz is necessary for cardiac septum development in mice.
• MEIS2 variation has been associated with cleft palate and cardiac septum anomalies in humans.
• The process provides a model for studying mesodermal contributions to organ morphogenesis.
• It links developmental gene regulatory networks to clinically observed structural heart defects.
• It supports the design of knockout and knock-in models to test candidate septation genes.
• It helps interpret human genetic variants found in patients with septal defects.
• It informs research on the timing and cell lineages that build the atrial and ventricular septa.
• It provides a framework for comparing normal and abnormal septation in animal models.
What Happens During cardiac septum development?
Specification of septal precursor cells
In simple terms: First, the embryo sets aside the cells that will build the wall between the heart chambers.
Cardiac septum development begins with the specification of precursor cells within the developing heart. Mesodermal populations contribute to the septal structures, and genetic evidence shows that mesodermal expression of Moz is necessary for cardiac septum development. This step establishes the cell populations that will later form the atrial and ventricular septa.
Formation of the primary septum
In simple terms: The specified cells then organize into an initial partition.
After specification, the precursor cells organize into a primary septum. The anatomy of the heart revisited emphasizes that the septal structures are integral to the chamber arrangement of the mature heart. The atrial septum in particular develops through a series of overlapping tissue contributions that create a temporary and then a definitive partition.
Growth and remodeling of the atrial septum
In simple terms: The initial wall is reshaped into the final atrial partition.
The atrial septum is not a simple static sheet; it develops through coordinated growth and remodeling events that produce the mature interatrial partition. This remodeling ensures that the atrial septum separates the atria while allowing the fetal circulation to operate before birth. The fetal circulation relies on specific shunts and septal arrangements that are later remodeled after birth.
Ventricular septation and chamber separation
In simple terms: The lower chambers are also divided by a growing wall.
Ventricular septation completes the separation of the left and right ventricles. The process is part of the broader progression of a cardiac septum from initial formation to mature structure. Defects in this step produce ventricular septal defects, which are among the congenital anomalies linked to abnormal cardiac septum development.
Maturation and integration with the conduction system
In simple terms: Finally, the septum matures and becomes part of the working heart.
Once formed, the septum matures and integrates with the rest of the heart, including the conduction system and the fibrous skeleton. The anatomy of the heart revisited highlights that the mature heart is a complex arrangement of chambers and septa that must function as a coordinated pump. This maturation step is the endpoint of GO:0003279, which explicitly extends to the mature structure.
Key Genes Involved in GO:0003279 cardiac septum development
The following genes and proteins have been experimentally implicated in cardiac septum development or in related human septal anomalies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Moz | Mesodermal transcription factor required for cardiac septum development | Knockout models show septal defects; used to test mesodermal contribution to septation |
| MEIS2 | Homeodomain transcription factor associated with cleft palate and cardiac septum anomalies | Human genetic evidence links MEIS2 to septal and palatal defects |
| GATA4 | Cardiac transcription factor broadly involved in heart development | Candidate for septation studies based on general cardiac developmental roles |
| NKX2-5 | Cardiac transcription factor important for heart morphogenesis | Frequently studied in congenital heart defect models |
| TBX5 | Transcription factor involved in heart and limb development | Relevant to septation because of its role in cardiac chamber formation |
| TBX1 | Transcription factor implicated in outflow tract and septal development | Used in models of conotruncal and septal defects |
| MEF2C | Myocyte enhancer factor involved in cardiac development | Candidate for studies of myocardial contributions to septation |
| HAND1 | Basic helix-loop-helix factor in cardiac development | Studied in ventricular and septal morphogenesis |
| HAND2 | Basic helix-loop-helix factor in cardiac development | Studied in chamber and septal development |
| SRF | Serum response factor regulating cardiac gene expression | Relevant to myocardial growth during septation |
| MYOCD | Myocardin, cofactor for SRF in cardiac and smooth muscle | Candidate for myocardial differentiation during septation |
| BMP2 | Signaling ligand in heart development | Studied in septal and valve formation |
| BMP4 | Signaling ligand in heart development | Studied in outflow tract and septal morphogenesis |
| NOTCH1 | Signaling receptor in cardiac development | Linked to valve and septal anomalies in models |
| JAG1 | Notch ligand in cardiac development | Associated with cardiac outflow and septal defects |
| SEMA3C | Guidance molecule in cardiac development | Studied in outflow tract and septal patterning |
| PITX2 | Transcription factor in left-right asymmetry and heart development | Relevant to asymmetric septal morphogenesis |
How Is cardiac septum development Regulated?
Cardiac septum development is regulated by a combination of mesodermal transcription factors and signaling pathways. Genetic evidence shows that mesodermal expression of Moz is necessary for cardiac septum development, indicating that Moz acts as a regulator of the septation program. MEIS2 has also been implicated in the development of cleft palate and cardiac septum, suggesting that homeodomain transcription factors modulate septal morphogenesis. The fetal circulation provides the physiological context in which septation must occur, and its shunts and flow patterns influence how the septa mature. The atrial septum in particular is regulated by coordinated growth and remodeling events that are sensitive to developmental timing.
cardiac septum development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Moz | Cardiac septum defects in mice | Knockout mouse and conditional mesodermal knockout |
| MEIS2 | Cleft palate and cardiac septum anomalies | Knock-in or knockout cell and animal models |
| GATA4 | Congenital heart defects including septal defects | Knockout and point-mutation models |
| NKX2-5 | Congenital heart defects and conduction anomalies | Knock-in reporter and knockout models |
| TBX5 | Holt-Oram syndrome with septal defects | Patient-derived iPSC and knock-in models |
Congenital heart defects and septal anomalies
Abnormal cardiac septum development is a major cause of congenital heart defects, including atrial and ventricular septal defects. Because GO:0003279 covers the entire progression from initial formation to mature structure, defects at any stage can produce clinically significant malformations. Mouse models with disrupted Moz show septal defects, providing causal evidence that specific genes are required for normal septation.
Cleft palate with cardiac septum anomalies
Human genetic evidence has linked MEIS2 to the development of cleft palate and cardiac septum anomalies, indicating that some patients with combined palatal and cardiac septal defects may carry variants in this gene. This association broadens the clinical relevance of cardiac septum development beyond isolated heart defects.
Fetal circulation and perinatal adaptation
The fetal circulation depends on specific septal and shunt arrangements that must be remodeled after birth. Disruption of cardiac septum development can therefore present as a failure of perinatal circulatory adaptation, underscoring the importance of the process for both prenatal and postnatal physiology.
From cardiac septum development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for cardiac septum development? | Knockout mouse or CRISPR knockout cell model |
| Does a specific patient variant cause septal defects? | Point-mutation knock-in model |
| Where and when is gene X expressed during septation? | Tagged knock-in reporter model |
| Can overexpression of gene X rescue septation? | Overexpression transgenic model |
| Which cell lineages contribute to the septum? | Lineage-tracing knock-in model |
| Does gene X interact with MEIS2 in septation? | Double knockout or epistasis model |
How to Study the cardiac septum development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Origin and fate of septal precursor cells | Mapping contributions to atrial and ventricular septa |
| Single-cell RNA-seq | Gene expression programs in developing heart cells | Identifying septation-associated genes |
| Mouse knockout | Requirement of a gene for septation | Testing Moz and other candidates |
| Human genetic association | Variants linked to septal anomalies | Interpreting MEIS2 and other loci |
| Immunohistochemistry | Protein localization in the developing septum | Validating expression patterns |
| Echocardiography | Structural and functional septal defects | Phenotyping animal models |
| CRISPR knockout screens | Genes required for septal cell growth | Discovering new septation regulators |
| Reporter knock-in | Dynamic expression during septation | Live imaging of septal development |
Genetic lineage tracing and imaging
Lineage tracing with tagged knock-in alleles allows researchers to follow the cells that build the cardiac septa over time. Combined with imaging, this approach reveals how precursor populations contribute to the atrial and ventricular septa.
Transcriptomics and single-cell RNA sequencing
Transcriptomic profiling of developing hearts can identify genes whose expression changes during septation, nominating candidates such as Moz and MEIS2 for functional testing. Single-cell approaches help resolve the cell types involved in septal morphogenesis.
Mouse genetics and knockout studies
Mouse knockout studies provide causal evidence for gene function in cardiac septum development; for example, loss of mesodermal Moz causes septal defects. These models are essential for linking candidate genes to the GO:0003279 process.
Human genetics and variant interpretation
Human genetic studies can associate variants with septal anomalies, as shown for MEIS2 in cleft palate and cardiac septum. Such findings guide functional experiments in cell and animal models.
How CRISPR Can Be Used to Study GO:0003279 cardiac septum development
Knockout
CRISPR knockout of candidate genes such as Moz can test whether they are required for cardiac septum development, mirroring the septal defects seen in mesodermal Moz mutants. Knockout cell models provide a rapid first-pass screen before animal studies.
Point Mutation
Point-mutation knock-in models allow researchers to test whether specific human variants, for example in MEIS2, are causal for septal anomalies rather than merely associated. This approach distinguishes pathogenic variants from benign polymorphisms.
Knock-in
Tagged knock-in reporters can mark the cells that contribute to the cardiac septa, enabling lineage tracing and dynamic expression analysis during septation. Knock-in of human disease alleles into model systems supports functional interpretation of patient variants.
Overexpression
Overexpression models can test whether increased dosage of a septation gene, such as Moz or MEIS2, alters cardiac septum development. These experiments complement loss-of-function studies by revealing dosage sensitivity.
How EDITGENE Supports cardiac septum development Research
Researchers studying cardiac septum development-related genes often need to determine whether a candidate gene is causally involved in septation or merely correlated with it. EDITGENE provides the CRISPR tools and models needed to move from candidate lists to functional evidence.
Contact EDITGENE today to design your custom CRISPR model for cardiac septum development research.
Frequently Asked Questions About cardiac septum development
What is cardiac septum development?
Cardiac septum development (GO:0003279) is the progression of a cardiac septum over time, from its initial formation to the mature structure.
What genes are involved in cardiac septum development?
Genes experimentally implicated include Moz, which is required in mesoderm for cardiac septum development, and MEIS2, which has been linked to cleft palate and cardiac septum anomalies.
What is the GO ID for cardiac septum development?
The GO ID is GO:0003279, a biological_process term with the synonym heart septum development.
Why is cardiac septum development important?
It separates the heart into four chambers and is essential for the mature circulation; defects cause congenital heart defects.
How is cardiac septum development studied?
It is studied with mouse genetics, lineage tracing, transcriptomics and human variant analysis.
What happens when cardiac septum development fails?
Failure can produce atrial or ventricular septal defects and other congenital heart anomalies.
Is Moz required for cardiac septum development?
Yes, mesodermal expression of Moz is necessary for cardiac septum development in mice.
What is the role of MEIS2 in septation?
MEIS2 has been associated with cleft palate and cardiac septum anomalies, suggesting a role in septal development.
Can CRISPR be used to study cardiac septum development?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test candidate genes such as Moz and MEIS2.
What models are used for cardiac septum development research?
Common models include knockout mice, lineage-tracing knock-ins and patient-variant knock-in cells.
Conclusion
Cardiac septum development (GO:0003279) is a fundamental developmental process that builds the partitions separating the heart chambers, and its failure underlies common congenital heart defects. Experimental work has identified key regulators such as Moz and MEIS2, providing a foundation for mechanistic and translational studies. CRISPR-based knockout, point-mutation, knock-in and overexpression models now make it possible to test candidate septation genes with precision.
References
- 1. Anderson RH et al.. 1996. The anatomy of the heart revisited.. Anat Rec 246(1):1-7 PMID: 8876818
- 2. Kiserud T et al.. 2004. The fetal circulation.. Prenat Diagn 24(13):1049-59 PMID: 15614842
- 3. Anderson RH et al.. 2002. Development and structure of the atrial septum.. Heart 88(1):104-10 PMID: 12067964
- 7. Vanyai HK et al.. 2015. Mesodermal expression of Moz is necessary for cardiac septum development.. Dev Biol 403(1):22-9 PMID: 25912687
- 8. Crowley MA et al.. 2010. Further evidence for the possible role of MEIS2 in the development of cleft palate and cardiac septum.. Am J Med Genet A 152A(5):1326-7 PMID: 20425846
